Updated July 2026 · 10 min read

Massive Transfusion Protocol for ICU Nurses 2026

Part of the ICU Emergencies Hub — browse every related guide in one place.

A patient is bleeding faster than you can replace it, and the usual "type and cross, hang a unit" rhythm falls apart. The massive transfusion protocol (MTP) exists for exactly this moment: it turns a chaotic, product-by-product scramble into a pre-packed, ratio-driven delivery system so the blood bank, the team, and the nurse at the bedside are all running the same play.

Why a protocol instead of unit-by-unit

In massive hemorrhage the patient isn't just losing red cells — they're losing whole blood, which means clotting factors and platelets are draining away at the same rate. If you replace only packed red cells (or worse, crystalloid), you dilute what little clotting ability remains and drive a self-worsening cycle: bleeding causes coagulopathy, which causes more bleeding. This is one leg of the "lethal triad" of trauma — coagulopathy, hypothermia, and acidosis, each of which makes the other two worse. MTP is built to interrupt that spiral by delivering a balanced resuscitation that looks more like the whole blood the patient is losing.

When to activate

The exact trigger varies by facility, but the theme is the same: don't wait for the labs to confirm what the eyes already see. Common activation cues include ongoing hemorrhage with hemodynamic instability, an expectation of needing many units in a short window, or a validated scoring tool in trauma (such as the ABC score). The single biggest failure mode is activating late. Once MTP is called, the blood bank begins releasing product in pre-packed coolers on a defined schedule so the team never runs dry mid-resuscitation.

The 1:1:1 ratio

The best-known MTP framework, supported by the PROPPR trial, is a balanced 1:1:1 ratio of plasma to platelets to red cells — approximating whole blood. Many centers now use whole blood directly where available. The point for the nurse isn't to memorize a single number but to understand why the products come together: giving red cells alone leaves the patient anemic-corrected but still unable to clot.

The four metabolic traps

Rapid, high-volume transfusion predictably deranges the patient's chemistry, and these complications are where an alert nurse changes outcomes.

Hypocalcemia (the big one). Stored blood is preserved with citrate, which binds calcium. Pour in product fast and the citrate binds the patient's ionized calcium, dropping it low enough to worsen coagulopathy and depress cardiac function. Ionized calcium is monitored closely during MTP and replaced — citrate toxicity is hypocalcemia. Watch for it and expect calcium to be given.

Hyperkalemia. Older stored red cells leak potassium; giving many units quickly can spike the serum potassium, especially in renal impairment. Watch the ECG and the potassium. (Paradoxically, some patients later drift hypokalemic as cells recover — the number moves, so keep checking.)

Hypothermia. Cold product cools the patient, and cold blood doesn't clot. Use a fluid warmer for red cells and plasma (never for platelets), warm the room, and use forced-air warming. Hypothermia is a leg of the lethal triad you can directly prevent at the bedside.

Acidosis. Hypoperfusion from shock, plus the acid load of stored blood, drives a metabolic acidosis that further impairs clotting and cardiac performance. It resolves with source control and adequate resuscitation, not with chasing the pH.

Access, monitoring, and the team

MTP is a logistics event as much as a clinical one. You need large-bore access — ideally two large peripheral IVs, a rapid-transfuser catheter, or a central line — because product has to move fast. A rapid infuser that warms and pressurizes is ideal. Someone owns the runner role between blood bank and bedside; someone documents each unit and the running totals; someone tracks the ratio. Serial labs (ionized calcium, potassium, hemoglobin, fibrinogen, coagulation studies or a viscoelastic test like TEG/ROTEM where available) guide adjustments. In trauma, tranexamic acid is given early — ideally within three hours — to reduce clot breakdown.

Knowing when to stop

MTP ends when the source of bleeding is controlled and the patient stabilizes — not simply when a lab crosses a line. The surgeon or proceduralist controlling the hemorrhage, the trend in hemodynamics, and the coagulation picture together tell the team it's time to deactivate. Once stopped, reconcile the products given, return unused units, and transition to targeted correction of whatever labs remain off.

What the nurse holds together

In a massive transfusion the nurse is the point where the protocol meets the patient: getting the access, keeping the blood warm, moving product fast without giving the wrong thing through the wrong line, catching the calcium drop and the potassium spike before they become an arrest, and keeping an accurate count so the team knows exactly what's been given. The bleeding gets controlled in the OR or IR suite — but whether the patient survives the trip there often comes down to how well the resuscitation was run at the bedside. Related reading: calcium chloride vs gluconate, hyperkalemia emergency treatment, and tranexamic acid (TXA).